According to recent media publications, the Food and Drug Administration has approved the use of Levemir (insulin detemir) for Type 1 diabetes in children ages 2 to 5 years. According to Novo Nordisk, Levemir, although approved for use in older children and adults for both Type 1 and Type 2 diabetes, is now the first FDA approved basal insulin analog for younger children. Currently there are only two types of basal insulin on the market for application in multiple daily injections (MDI):...